Last updated: 10 September 2024 at 8:33pm EST

Benjamin Palleiko Net Worth




The estimated Net Worth of Benjamin L Palleiko is at least $4.41 Milhão dollars as of 6 September 2024. Mr. Palleiko owns over 15,625 units of KalVista Pharmaceuticals Inc stock worth over $2,767,389 and over the last 8 years he sold KALV stock worth over $613,234. In addition, he makes $1,028,480 as Chief Financial Officer e Chief Business Officer at KalVista Pharmaceuticals Inc.

Mr. Palleiko KALV stock SEC Form 4 insiders trading

Benjamin has made over 15 trades of the KalVista Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 15,625 units of KALV stock worth $167,500 on 6 September 2024.

The largest trade he's ever made was exercising 51,031 units of KalVista Pharmaceuticals Inc stock on 17 May 2024 worth over $547,052. On average, Benjamin trades about 11,478 units every 70 days since 2016. As of 6 September 2024 he still owns at least 258,152 units of KalVista Pharmaceuticals Inc stock.

You can see the complete history of Mr. Palleiko stock trades at the bottom of the page.





Benjamin Palleiko biography

Benjamin L. Palleiko serves as Chief Financial Officer, Chief Business Officer of the Company. Mr. Palleiko joined as Chief Financial Officer of KalVista Limited in August 2016 and was appointed as our Chief Financial Officer in November 2016. Mr. Palleiko was appointed as our Chief Business Officer in addition to his role as Chief Financial Officer in March 2019. Prior to joining us, Mr. Palleiko was co-Founder and CEO of Cielo Therapeutics, Inc. from 2012 until June 2016. He previously was Senior Vice President and Chief Financial Officer of Ore Pharmaceutical Holdings Inc. and Penwest Pharmaceuticals Co. Earlier in his career Mr. Palleiko was an investment banker with the firms Robertson Stephens and SunTrust Bank. Mr. Palleiko holds a B.A. in Quantitative Economics from Tufts University and an M.B.A. in Finance and M.A. in International Relations from the University of Chicago. He served as a Naval Aviator in the U.S. Navy.

What is the salary of Benjamin Palleiko?

As the Chief Financial Officer e Chief Business Officer of KalVista Pharmaceuticals Inc, the total compensation of Benjamin Palleiko at KalVista Pharmaceuticals Inc is $1,028,480. There are 2 executives at KalVista Pharmaceuticals Inc getting paid more, with Thomas Crockett having the highest compensation of $1,731,160.



How old is Benjamin Palleiko?

Benjamin Palleiko is 54, he's been the Chief Financial Officer e Chief Business Officer of KalVista Pharmaceuticals Inc since 2019. There are 11 older and 6 younger executives at KalVista Pharmaceuticals Inc. The oldest executive at KalVista Pharmaceuticals Inc is Arnold Oronsky, 80, who is the Independent Director.

What's Benjamin Palleiko's mailing address?

Benjamin's mailing address filed with the SEC is C/O KALVISTA PHARMACEUTICALS, INC., 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA, 02142.

Insiders trading at KalVista Pharmaceuticals Inc

Over the last 8 years, insiders at KalVista Pharmaceuticals Inc have traded over $74,823,944 worth of KalVista Pharmaceuticals Inc stock and bought 4,877,063 units worth $58,591,487 . The most active insiders traders include Holdings A/S Novo, Capital Management, L.P.Ra ..., eRajeev M. Shah. On average, KalVista Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $835,088. The most recent stock trade was executed by Benjamin L Palleiko on 6 September 2024, trading 15,625 units of KALV stock currently worth $167,500.



What does KalVista Pharmaceuticals Inc do?

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.



What does KalVista Pharmaceuticals Inc's logo look like?

KalVista Pharmaceuticals Inc logo

Complete history of Mr. Palleiko stock trades at KalVista Pharmaceuticals Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
6 Sep 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 15,625 $12.37 $193,281
6 Sep 2024
258,152
17 Aug 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 30,195 $12.00 $362,340
17 Aug 2024
256,742
6 Jun 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 15,625 $11.85 $185,156
6 Jun 2024
232,012
17 May 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 51,031 $11.92 $608,290
17 May 2024
238,346
17 Feb 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 51,029 $14.86 $758,291
17 Feb 2024
210,117
14 Feb 2024 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Venda 40,855 $15.01 $613,234
14 Feb 2024
159,088
17 Nov 2023 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 30,197 $8.12 $245,200
17 Nov 2023
125,451
17 Aug 2023 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 30,195 $10.93 $330,031
17 Aug 2023
108,321
17 Feb 2023 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 9,363 $8.12 $76,028
17 Feb 2023
77,753
11 Jan 2023 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 9,364 $6.82 $63,862
11 Jan 2023
82,163
17 Nov 2022 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 2,419 $5.37 $12,990
17 Nov 2022
69,112
17 Aug 2022 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 2,418 $15.21 $36,778
17 Aug 2022
67,418
23 Feb 2021 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 29,642 $6.74 $199,787
23 Feb 2021
94,642
30 Dec 2020 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 358 $6.74 $2,413
30 Dec 2020
32,858
18 Apr 2019 Benjamin L Palleiko
CHIEF EXECUTIVE OFFICER
Exercício de opção 3,073 $7.81 $24,000
18 Apr 2019
34,500


KalVista Pharmaceuticals Inc executives and stock owners

KalVista Pharmaceuticals Inc executives and other stock owners filed with the SEC include: